Stay updated on Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The revision label in the page footer changed to v3.6.3, indicating a minor site build update rather than a content change.
    Difference
    0.0%
    Check dated 2026-07-03T22:57:46.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    An administrative revision entry (v3.6.2) was added to the study history and an older revision (v3.6.0) was removed, reflecting metadata maintenance of the record.
    Difference
    0.2%
    Check dated 2026-06-26T23:23:09.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Recruitment status was updated to no longer looking for participants, indicating enrollment is closed for this study. The record version was updated from v3.5.5 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-12T16:31:28.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.5.5 appears as the latest entry on the history page, replacing the previous v3.5.4 entry. The history is updated to reflect the most recent release.
    Difference
    0.0%
    Check dated 2026-06-05T12:51:14.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The record history now shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates a new version of the page was published.
    Difference
    0.0%
    Check dated 2026-05-15T02:07:46.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The Record History gains a new entry for Revision: v3.5.3 and removes Revision: v3.5.2, indicating a page revision was posted. This reflects a site-level version update rather than changes to the trial information.
    Difference
    0.0%
    Check dated 2026-04-30T16:34:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.